Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACEITeffic: Ivermectin + Albendazole for Trichuriasis
NCT06037876Phase 3Completed
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in trichuriasis. Started Oct 2023; status: completed.
02
Drugs
ivermectin
03
Conditions
trichuriasis
Beyond the preview
Go deeper on NCT06037876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037876.